{"transactions":[{"id":4107977,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":170511,"kind":"person","name":"Smith Rachel","position":1,"cik":"0001593089","reported_name":"Smith Rachel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of R&D"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-04T22:05:10.000Z","date":"2017-12-22","kind":"exercise","acquired":false,"shares":20748,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.16,"exercise_date":"2008-01-01","expiration_date":"2018-01-01","underlying":"Common Stock","underlying_shares":20748},"source":{"system":"sec-edgar","filing":"0001144204-18-000868","document":"tv482723_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420418000868/tv482723_4.xml","form_type":"4"}},{"id":4107976,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":170511,"kind":"person","name":"Smith Rachel","position":1,"cik":"0001593089","reported_name":"Smith Rachel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of R&D"}}],"security":"Common Stock","published_at":"2018-01-04T22:05:10.000Z","date":"2017-12-22","kind":"tax_withholding","acquired":false,"shares":2244,"price":1.48,"value":3321.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects 2,244 shares withheld by the Issuer at the market price of $1.48 per share to fund the cashless exercise of 20,748 options."}],"balance_after":18504,"source":{"system":"sec-edgar","filing":"0001144204-18-000868","document":"tv482723_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420418000868/tv482723_4.xml","form_type":"4"}},{"id":4107975,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":170511,"kind":"person","name":"Smith Rachel","position":1,"cik":"0001593089","reported_name":"Smith Rachel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of R&D"}}],"security":"Common Stock","published_at":"2018-01-04T22:05:10.000Z","date":"2017-12-22","kind":"exercise","acquired":true,"shares":20748,"price":0.16,"value":3319.68,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 22, 2017, the Reporting Person exercised, via cashless exercise, stock options for 20,748 shares of Common Stock. The exercise price was $0.16 per share and the exercise was subject to the terms and conditions of a Stock Option Award which was granted on January 1, 2008 under the Company's 2006 Stock Option Plan."}],"balance_after":20748,"source":{"system":"sec-edgar","filing":"0001144204-18-000868","document":"tv482723_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420418000868/tv482723_4.xml","form_type":"4"}},{"id":4107974,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":170511,"kind":"person","name":"Smith Rachel","position":1,"cik":"0001593089","reported_name":"Smith Rachel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of R&D"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-04T22:04:35.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the stock option award shall vest on the first day of each month, commencing February 1, 2018, until the stock option becomes fully vested and exercisable. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":50000,"derivative":{"exercise_price":1.57,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-18-000865","document":"tv482722_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420418000865/tv482722_4.xml","form_type":"4"}},{"id":4503385,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":170511,"kind":"person","name":"Smith Rachel","position":1,"cik":"0001593089","reported_name":"Smith Rachel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of R&D"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-05T02:46:12.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the stock option award shall vest on the first day of each month, commencing February 1, 2017, until the stock option becomes fully vested and exercisable. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"1/48th of the shares subject to the stock option award shall vest on the first day of each month, commencing February 1, 2017, until the stock option becomes fully vested and exercisable. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":35000,"derivative":{"exercise_price":2.55,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001144204-17-000708","document":"v456184_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420417000708/v456184_4.xml","form_type":"4"}}]}